Post by : Saif
Al-Najjar
The mergers and acquisitions (M&A) sector is currently experiencing significant momentum, and Michal Katz, the leading figure in investment and corporate banking at Mizuho Americas, highlights that this trend shows no signs of abating. At the Reuters NEXT conference in New York, she elaborated on the factors fueling the bustling dealmaking environment for 2025 and beyond.
This year has already witnessed a surge of substantial transactions, termed megadeals, each valued over $10 billion, with their total worth skyrocketing to around $1.3 trillion—more than double last year's figures. Noteworthy instances include an $85 billion rail agreement, a $40 billion data center deal, and the largest leveraged buyout recorded: the $55 billion acquisition of Electronic Arts. These substantial actions underscore the ambition of corporations striving for growth and transformation.
Katz explained that many CEOs are compelled to expand as traditional business models face disruption from artificial intelligence. AI is redefining operational methods, customer engagement, and future planning, compelling leaders to prepare their organizations for substantial long-term transitions. This climate has fostered a strong "pent-up demand" for mergers, with companies that delayed during turbulent periods now poised for action.
In addition, Katz predicts an influx of medium-sized transactions under $10 billion alongside more megadeals in the coming year. These smaller deals are vital for the ongoing activity of private-equity firms, which are keen on unloading older assets in a favorable market that promises sound returns.
Another noteworthy point from Katz’s insights is the escalation of shareholder activism. In 2025, investors are taking a more assertive stance, urging companies to make audacious decisions, divest certain segments, or pursue mergers. This demand for "event-driven exits" fosters additional transactions and strategic shifts.
Healthcare, while technology firms have predominantly led the market in 2025, is emerging as a bustling arena for acquisitions. Major deals such as Pfizer’s acquisition of Metsera, Abbott Labs’ takeover of Exact Sciences, and proactive strategies from Thermo Fisher and Novartis illustrate that leading healthcare organizations are actively preparing for future expansion. This evolution suggests that M&A activity is diversifying beyond its traditional tech-centric concentration.
The private credit arena, however, has encountered challenges, with several prominent companies declaring bankruptcy, raising flags regarding lending practices. Katz referred to these situations as "idiosyncratic," indicating that they are not indicative of a broader market downturn. Nevertheless, lenders and investors are now exercising greater caution, demanding improved documentation, transparency, and secure loan structures. This enhanced vigilance could fortify the market by minimizing riskier choices.
Katz's salient message at the conference was clear: the dynamics that have characterized 2025 as a prosperous year for dealmaking—growth aspirations, AI-fueled transformations, shareholder pressures, and active private-equity movements—are likely to underpin a bustling M&A market into 2026. As firms strategize for the future, many are gearing up for sustained investments that will redefine their sectors for the foreseeable future.
As technology continually reshapes global markets, the upcoming year could unveil even more unexpected alliances and transformative mergers.
English
